Table 1.
Cell Surface markers for undifferentiated MSCs.
Tissue reservoir | Positive markers | Negative markers | References |
---|---|---|---|
Bone marrow | CD13, CD29, CD44, CD49a–f, CD51, CD73, CD90, CD105, CD106, CD166, and STRO-1 | CD11b, CD14, CD19 CD34, CD45, and CD79α | Halfon et al., 2011; Barry and Murphy, 2013 |
Adipose | CD44, CD90, and CD105 | CD45, CD34, and CD133 | Dominici et al., 2006 |
Cartilage | CD9, CD49e, CD90, CD166, Notch1, and STRO-1 | CD45, CD133/−1, and −2 | Alsalameh et al., 2004; Fickert et al., 2004; Williams et al., 2010 |
Synovial membrane | CD44, CD90, CD105, and CD147 | CD34, CD45, CD117, and CD31 | De Bari et al., 2001b; Sakaguchi et al., 2005 |
Synovial fluid | CD10, CD13, CD40, CD44, CD55, CD73, CD90, CD 105, CD 166, and D7-FIB | CD11b, CD34, CD45, and CD271 | Jones et al., 2004; Krawetz et al., 2012 |
Fat pad | CD13, CD29, CD44, CD90, and CD105 | CD34, CD56, CD271, and STRO1 | Khan et al., 2012 |
Periosteal membrane | CD9, CD73, CD90, CD105, SH2, SH3, and SH4 | CD11b, CD14, CD19, CD34, CD45, CD79a, and HLA-DR | Lim et al., 2005; Chang and Knothe Tate, 2012 |
Trabecular bone | CD44, CD64, CD90, CD105, CD147, and CD166 | CD31, CD34, CD45, and CD117 | Sakaguchi et al., 2004 |
Muscle | CD34, CD144, and CD56 | Zheng et al., 2007 |